stockrowBristol Myers Squibb Company
BMY Healthcare Drug Manufacturers General
Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow BMY
Alert me
Bristol Myers Squibb Company (BMY) Revenue growth
Bristol Myers Squibb Company's revenue growth over the twelve months to 30 June 2026 was 3.11%, up 3.3 percentage points from fiscal 2025 (−0.22%). Over the past ten years it has ranged from −2.50% (fiscal 2023) to 62.6% (fiscal 2020); the current reading is higher than 27% of that period. That is below the Drug Manufacturers General industry median of 6.66% and below the Healthcare sector median of 8.04%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −0.22% | (7.54) |
| FY2024 | 7.32% | 9.82 |
| FY2023 | −2.50% | (2.01) |
| FY2022 | −0.49% | (9.58) |
| FY2021 | 9.09% | (53.53) |
| FY2020 | 62.6% | 46.73 |
| FY2019 | 15.9% | 7.30 |
| FY2018 | 8.59% | 1.65 |
| FY2017 | 6.94% | (10.37) |
| FY2016 | 17.3% | 13.02 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 5.74% | 3.17 |
| Mar 2026 | 2.57% | 1.27 |
| Dec 2025 | 1.30% | (1.47) |
| Sep 2025 | 2.77% | 2.21 |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| SNY Sanofi compare | 21.3% |
| NVO Novo Nordisk A/S compare | 13.2% |
| AMGN Amgen Inc. compare | 9.10% |
| GSK GSK PLC Sponsored ADR compare | 8.72% |
| AZN AstraZeneca PLC compare | 8.61% |
| GILD Gilead Sciences, Inc. compare | 5.52% |
| BMY Bristol Myers Squibb Company | 3.11% |
| NVS Novartis AG compare | 2.73% |
| PFE Pfizer Inc. compare | −0.21% |
| Drug Manufacturers General industry median | 6.66% |
| Healthcare sector median | 8.04% |
| Market median | 7.24% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on BMY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement